Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial.
Thomas FilleronSophie Le GuellecChristine ChevreauBastien CabarrouTom LesluyesSabrina LodinAngélique MassoubreMuriel MounierMuriel PoublancFrédéric ChibonThibaud ValentinPublished in: BMC cancer (2020)
ClinicalTrials.gov identifier: NCT04307277 Date of registration: 13 March 2020.